[{"AccountsPayableCurrent_0_Q1_USD":30527000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":2784000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":108.68,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":6478000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":24018000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":36293000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":13254000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-2118000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":336675000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":107674000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":401129000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":0.0,"RestrictedCashCurrent_0_Q1_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":361800000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":963000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":118091000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-906000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-906000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-203517000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":23016000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1147000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":99.92,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":3248000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":2500000.0,"OtherAssetsNoncurrent_0_Q1_USD":79192000.0,"Goodwill_0_Q1_USD":13128000.0,"MarketableSecurities_0_Q1_USD":671728000.0,"MarketableSecuritiesCurrent_0_Q1_USD":564054000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":5355000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":36335000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q1_USD":2302000.0,"RestrictedCashNoncurrent_0_Q1_USD":54500000.0,"ProceedsFromStockPlans_1_Q1_USD":800000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":101421000.0,"OtherNoncashIncomeExpense_1_Q1_USD":1387000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":194469000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":179962000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":20380000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"InvestmentsAndCash_0_Q1_USD":1020000000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-20557000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"CostOfGoodsAndServicesSold_1_Q1_USD":1025000.0,"EquitySecuritiesFvNiGainLoss_1_Q1_USD":-4520000.0,"EquitySecuritiesFvNi_0_Q1_USD":8350000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":1125000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":147686000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":1110000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":107072000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":15000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q1_USD":40614000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":9791000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":6355000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":19420000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":4869000.0,"EquitySecuritiesFvNiCost_0_Q1_USD":20017000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":1125000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-3108000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":75.65,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-2484463000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":153920000.0,"ProfitLoss_1_Q1_USD":-202611000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":10676000.0,"NetIncomeLoss_1_Q1_USD":-202611000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-206121000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":224578000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":963000.0,"LiabilitiesCurrent_0_Q1_USD":184422000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1529104000.0,"Liabilities_0_Q1_USD":408671000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":10984000.0,"Revenues_1_Q1_USD":21863000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-9519000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-202517000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-3.64,"CostsAndExpenses_1_Q1_USD":225288000.0,"CommonStockValue_0_Q1_USD":556000.0,"CommonStockSharesOutstanding_0_Q1_shares":55620000.0,"CommonStockSharesIssued_0_Q1_shares":55620000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":346629000.0,"AssetsCurrent_0_Q1_USD":967467000.0,"Assets_0_Q1_USD":1529104000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":8063000.0,"AdditionalPaidInCapital_0_Q1_USD":3607139000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-2799000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":94000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":14425000.0,"StockholdersEquity_0_Q1_USD":1120433000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":37.71,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":108.68,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":6478000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":148.55,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":132000.0,"PrepaidExpenseCurrent_0_Q1_USD":40209000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-4447000.0,"InterestReceivable_0_Q1_USD":2900000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1_Q1_USD":0.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":2604000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":194232000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":40312000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":55590000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":750000.0,"ShareBasedCompensation_1_Q1_USD":36293000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":73248000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":154123000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":10.0,"OperatingIncomeLoss_1_Q1_USD":-203425000.0,"DepreciationAndAmortization_1_Q1_USD":4880000.0,"CommonStockSharesAuthorized_0_Q1_shares":125000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":20000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":1872000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]